ATS 2018 International Conference

Effects of a Potent and Selective p38α MAPK Inhibitor (CHF6297) in a Novel Model of Corticosteroid-Resistant Allergic Asthma [Board No. P946]

Location: Board no. P946

Session Type: Thematic Poster Session

Sunday

May

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Fabrizio Facchinetti

PhD
Chiesi Farmaceutici

Annemiek Dijkhuis

Msc
Academic Medical Centre/University of Amsterdam

Rene Lutter

Doctorate
Academic Medical Center;Academic Medical Center, University of Amsterdam;Academic Medical Centre/University of Amsterdam;AMC/University of Amsterdam

Gino Villetti

DVM
Chiesi Farmaceutici

Lara Ravanetti

PhD
Academic Medical Centre/University of Amsterdam

Tamara Dekker

BSc
Academic Medical Centre/University of Amsterdam

View Abstract

Effects of a Potent and Selective p38α MAPK Inhibitor (CHF6297) in a Novel Model of Corticosteroid-Resistant Allergic Asthma

Parent Sessions

A35 - ASTHMA CLINICAL STUDIES II
05-20-2018 9:15 AM - 4:15 PM

Event